Joseph DiMartino

BNY Mellon High Yield Strategies Fund is a non-diversified, closed-end management investment company. Its primary investment objective is to seek high current income. The firm invests its assets in income securities of U.S. issuers rated below investment grade quality or unrated income securities that The Dreyfus Corp., serving as the fund's investment manager and administrator. The company was founded on March 16, 1998 and is headquartered in New York, NY.

BNY Mellon Municipal Bond Infrastructure Fund, Inc. is a non-diversified closed-end management investment company. Its investment objective is to seek to provide as high a level of current income exempt from regular federal income tax as is consistent with the preservation of capital. The company was founded on April 26, 2013 and is headquartered in New York, NY.

BNY Mellon Investment Funds II, Inc. operates as a open-end management investment company. Its investment objective is to seek long-term capital appreciation. The company invests in equity securities of companies located, organized, or with a majority of assets or business in emerging market countries. The company was founded on November 1, 2013 and is headquartered in New York, NY.

BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. operates as a closed-end investment fund. The fund's investment objective is to seek high current income and to invest in credit instruments and other investments. The company is headquartered in New York, NY.

BNY Mellon Absolute Insight Funds, Inc. engages in conducting, operating, and carrying on the business of an open-end management investment company. The company was founded on December 8, 2014 and is headquartered in New York, NY.

The Newark Group, Inc. manufactures and sells recycled paperboard products. Its products include concrete forming tubes, industrial grades, graphic board, looseleaf, books, and puzzle boards. The company was founded in 1912 and is headquartered in Cranford, NJ.

MDA is the nonprofit health agency dedicated to curing muscular dystrophy, ALS and related diseases by funding worldwide research. The Association also provides comprehensive health care and support services, advocacy and education. MDA combats neuromuscular diseases through programs of worldwide research, comprehensive medical and support services, and far-reaching professional and public health education. With national headquarters in Tucson, MDA has more than 200 offices across the country, sponsors some 200 hospital-affiliated clinics and supports more than 330 research projects around the world. MDA supports more research on neuromuscular diseases than any other private-sector organization in the world. MDA scientists are in the forefront of gene therapy research and have uncovered the genetic defects responsible for several forms of muscular dystrophy, Charcot-Marie-Tooth disease, a form of amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease), childhood spinal muscular atrophy and several other neuromuscular conditions. The Association's comprehensive services program includes diagnostic and follow-up medical consultations, flu shots, support groups, MDA summer camps for youngsters, a medical equipment program, assistance with equipment repairs and resource referral. Through its national advocacy program, MDA works to make life better for people with muscular dystrophy and related muscle diseases by providing representation in matters of public policy and research advancement, nationally and internationally; and facilitating active involvement in these areas by the people it serves. MDA was created in 1950 by a group of adults with muscular dystrophy, parents of children with muscular dystrophy and a physician-scientist studying the disorder. Since its earliest days, it has been energized by its number-one volunteer and national chairman, entertainer Jerry Lewis.

Part of The Bank of New York Mellon Corp., BNY Mellon Investment Management LLC is one of the largest asset managers in the world, with $2.20 trillion in assets under management as of March 31, 2021. The private company is based in Boston, MA. The company offers solutions across every major asset class, backed by the strength, stability, and presence of BNY Mellon. The CEO of the company is Hanneke Smits.